Results 91 to 100 of about 28,723 (210)

Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement

open access: yesThrombosis Journal, 2011
Background Patients undergoing elective total hip replacement (THR) surgery are at an increased risk for venous thromboembolic events (VTEs). Dalteparin and enoxaparin are recommended as thromboprophylaxis for at least 10 days in these patients.
Choe Yoonhee   +2 more
doaj   +1 more source

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients

open access: yes, 2012
Graham F Pineo1, Jay Lin2, Lieven Annemans31Department of Medicine, University of Calgary, Calgary, Alberta, Canada; 2Novosys Health, Flemington, NJ; 3Department of Medicine, Ghent University, Ghent and Brussels University, Brussels, BelgiumAbstract ...
Pineo GF, Annemans L, Lin J
core  

Enoxaparin sodium prevents intestinal microcirculatory dysfunction in endotoxemic rats

open access: yes, 2017
Introduction: During severe sepsis or septic shock, activation of the inflammatory and coagulatory systems can result in microcirculatory dysfunction as well as microvascular thrombosis, culminating in multiple organ dysfunction and death. Enoxaparin can
孫維仁;蔡瑞章;范守仁;柯文哲;王明鉅;葉育彰;林至芃   +1 more
core   +1 more source

Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis

open access: yesJournal of Nanotechnology, 2017
This study was based on the preparation, characterization, and animal in vivo experiments performed to evaluate nanoparticles of poly(ɛ-caprolactone) (PCL) and chitosan as carriers of enoxaparin.
Lucas Bessa Prado   +6 more
doaj   +1 more source

Economic Evaluation of Enoxaparin as Postdischarge Prophylaxis for Deep Vein Thrombosis (DVT) in Elective Hip Surgery [PDF]

open access: yes, 2000
ObjectivesClinical trials indicate enoxaparin thromboprophylaxis (Clexane) can be effective and safe when used in an outpatient setting and that extending the length of thromboprophylaxis with enoxaparin to the postdischarge period may be more effective ...
Richardson, Gerald Anthony   +2 more
core   +1 more source

Effectiveness of enoxaparin in preventing intraoperative fibrin formation during DMEK assessed in a before-and-after study

open access: yesScientific Reports
To demonstrate that enoxaparin in the irrigation saline solution can effectively prevent intraoperative fibrin formation (IFF) during Descemet membrane endothelial keratoplasty (DMEK) surgery without compromising graft viability, visual recovery, or ...
Pablo De-Arriba-Palomero   +9 more
doaj   +1 more source

Consumption pattern of enoxaparin in a non-teaching hospital (a cross-sectional prospective study)

open access: yesJournal of Pharmacoeconomics and Pharmaceutical Management, 2022
Background: Drug use evaluation studies are conducted to assess the pattern of prescribing and administration of a drug. Deep vein thrombosis is one of the most important clinical issues around the world.
Mohammadreza Rafati   +3 more
doaj  

Influence of low molecular weight heparins on immune system of surgical patients

open access: yesPerioperative Medicine, 2019
Venous thromboembolic complications are potentially dangerous complications to life in patients undergoing surgical intervention. The aim of the work is to study the safety of enoxaparin thromboprophylaxis by eliciting the effect of sodium enoxaparin (
O O Budnyuk   +4 more
doaj   +1 more source

Effect of enoxaparin on epithelial tight junctions of colon.

open access: yes, 2015
Immunostaining of (A) occludin and (B) claudin-4 in the distal colon of healthy and colitis mice treated with and without enoxaparin. Scale bar = 100 μm for 400 × magnification.
Sarron Randall-Demllo (776243)   +7 more
core   +1 more source

Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism

open access: yesHemaSphere, 2018
. Current guidelines recommend low-molecular-weight-heparins (LMWH) monotherapy for 3 to 6 months as first-line treatment for cancer-associated venous thromboembolism (VTE). In clinical practice, enoxaparin and nadroparin are common agents used. However,
Sake J. van der Wall   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy